1
|
Rubio-Gracia J, Giménez-López I, Damman K, Sánchez-Marteles M, Garcés-Horna V, Josa-Laorden C, de la Rica-Escuin M, Pérez-Calvo J. Presión intraabdominal y empeoramiento de la función renal durante las descompensaciones de la insuficiencia cardiaca. Un informe preliminar del estudio PIA. Rev Clin Esp 2019; 219:229-235. [DOI: 10.1016/j.rce.2018.09.022] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2018] [Revised: 08/13/2018] [Accepted: 09/04/2018] [Indexed: 12/20/2022]
|
2
|
Intraabdominal pressure and worsening renal function during decompensations of heart failure. A preliminary report from the PIA study. Rev Clin Esp 2019. [DOI: 10.1016/j.rceng.2018.09.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
3
|
Núñez J, Llàcer P, Bertomeu-González V, Bosch MJ, Merlos P, García-Blas S, Montagud V, Bodí V, Bertomeu-Martínez V, Pedrosa V, Mendizábal A, Cordero A, Gallego J, Palau P, Miñana G, Santas E, Morell S, Llàcer A, Chorro FJ, Sanchis J, Fácila L, Núñez J, Garcia-Blas S, Sanchis J, Bodí V, Santas E, Olivares M, Bonanad C, Bondanza L, Llàcer A, Chorro FJ, Bosch MJ, Merlos P, Gallego J, Palau P, Llàcer P, Mendizabal A, Miñana G, Pedrosa V, Salvador M, Camps A, Salvador G, Bertomeu-González V, Bertomeu-Martínez V, Cordero A, Moreno J, Quiles J, López Pineda A, Fácila L, Montagud V, Fonfria R, Jareño MT, Belchi J, Rumiz E, Morell S. Carbohydrate Antigen-125–Guided Therapy in Acute Heart Failure. JACC-HEART FAILURE 2016; 4:833-843. [DOI: 10.1016/j.jchf.2016.06.007] [Citation(s) in RCA: 59] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/01/2016] [Revised: 06/23/2016] [Accepted: 06/23/2016] [Indexed: 12/31/2022]
|
4
|
Núñez J, Núñez E, Bayés-Genís A, Fonarow GC, Miñana G, Bodí V, Pascual-Figal D, Santas E, Garcia-Blas S, Chorro FJ, Rizopoulos D, Sanchis J. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE 2016; 6:685-696. [PMID: 27199489 DOI: 10.1177/2048872616649757] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
AIM Baseline values of N-terminal pro B-type natriuretic peptide (NT-proBNP) and carbohydrate antigen 125 (CA125) predict all-cause mortality in acute heart failure (AHF). However, there is limited information about the added prognostic benefit of using longitudinal values, and how this predictive ability is modified when modelling together. The aim of this study was to determine the mutually-adjusted association between the longitudinal trajectories of NT-proBNP and CA125 with all-cause mortality after an episode of AHF. METHODS AND RESULTS We included 946 consecutive patients discharged for AHF. NT-proBNP and CA125 were measured at each physician-patient encounter (median (interquartile range (IQR)):3 (2-4)). The effect on mortality (time-dependent modelling) was assessed using joint modelling (JM) and multi-state Markov. The mean age was 71±11 years and 51% exhibited left ventricular systolic dysfunction. At a median follow-up of 2.64 years (IQR=1.20-5.36), 498 patients died (52.6%). The observed trajectories of both biomarkers markedly differed over survival status, with sustained higher values in patients who died. After being adjusted by established risk factors and by each other, the baseline absolute change in CA125 and NT-proBNP were significantly associated to mortality (hazard ratio (HR)=1.05 (1.01-1.09); p=0.011 (area under the curve (AUC)=0.76) and HR=1.04 (1.02-1.06); p<0.001 (AUC=0.75), respectively). After merging the binary version of NT-proBNP (⩾1000 pg/ml) and CA125 (>35 U/ml) into a four-level variable, we found the highest risk when both were elevated, intermediate risk when either one was low, and lowest risk when both were low. CONCLUSION The combination of long-term longitudinal trajectories of CA125 and NT-proBNP improves risk stratification for all-cause mortality after a hospitalization for AHF.
Collapse
Affiliation(s)
- Julio Núñez
- 1 Servicio de Cardiología, Hospital Clínico Universitario, INCLIVA, Universitat de Valencia, Spain
| | - Eduardo Núñez
- 1 Servicio de Cardiología, Hospital Clínico Universitario, INCLIVA, Universitat de Valencia, Spain
| | - Antoni Bayés-Genís
- 2 Servicio de Cardiología, Hospital Universitari Germas Trias i Pujol, Spain
| | | | - Gema Miñana
- 1 Servicio de Cardiología, Hospital Clínico Universitario, INCLIVA, Universitat de Valencia, Spain
| | - Vicent Bodí
- 1 Servicio de Cardiología, Hospital Clínico Universitario, INCLIVA, Universitat de Valencia, Spain
| | | | - Enrique Santas
- 1 Servicio de Cardiología, Hospital Clínico Universitario, INCLIVA, Universitat de Valencia, Spain
| | - Sergio Garcia-Blas
- 1 Servicio de Cardiología, Hospital Clínico Universitario, INCLIVA, Universitat de Valencia, Spain
| | - Francisco J Chorro
- 1 Servicio de Cardiología, Hospital Clínico Universitario, INCLIVA, Universitat de Valencia, Spain
| | - Dimitris Rizopoulos
- 5 Department of Biostatistics, Erasmus University Medical Center, the Netherlands
| | - Juan Sanchis
- 1 Servicio de Cardiología, Hospital Clínico Universitario, INCLIVA, Universitat de Valencia, Spain
| |
Collapse
|